Sangamo Therapeutics
SGMO
#9116
Rank
NZ$0.21 B
Marketcap
NZ$0.53
Share price
15.38%
Change (1 day)
-53.24%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.77. In 2024 the company made an earnings per share (EPS) of NZ-$0.89.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-14.51%
2024NZ-$0.89
2022NZ-$2.190.81%
2021NZ-$2.1733.33%
2020NZ-$1.636.9%
2019NZ-$1.5222.54%
2018NZ-$1.241.43%
2017NZ-$1.23-31.37%
2016NZ-$1.7975.86%
2015NZ-$1.0248.72%
2014NZ-$0.68-17.02%
2013NZ-$0.829.3%
2012NZ-$0.75-39.44%
2011NZ-$1.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.49-2,631.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.08-3,356.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$15.45-2,106.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$6.46 738.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.99-1,656.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.79-1,761.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$3.15-509.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$3.19-513.64%๐Ÿ‡บ๐Ÿ‡ธ USA